Ocaliva 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25FMQMW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,751
Award facts
- Contract value 100% obligated
- $8,751.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $8,751.19, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the drug OCALIVA 10 MG TABLET 30S, with a period of performance through December 27, 2024.
DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.
The contract award does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a diverse array of pharmaceutical products to the Department of Defense (DoD) healthcare system.
Quick answers
Who was awarded contract SPE2DX25FMQMW?
SPE2DX25FMQMW was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on December 5, 2024.
How much is contract SPE2DX25FMQMW worth?
The government has obligated $8,751 on SPE2DX25FMQMW.
Is contract SPE2DX25FMQMW an order under another contract?
Yes. SPE2DX25FMQMW is a delivery order under SPE2DX15D9320, an indefinite delivery contract.
Was contract SPE2DX25FMQMW competed?
The extent of competition for SPE2DX25FMQMW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award